275 related articles for article (PubMed ID: 29127490)
1. Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis.
Guo VY; Cao B; Cai C; Cheng KK; Cheung BMY
Acta Diabetol; 2018 Jan; 55(1):87-98. PubMed ID: 29127490
[TBL] [Abstract][Full Text] [Related]
2. The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies.
Roshanzamir F; Miraghajani M; Rouhani MH; Mansourian M; Ghiasvand R; Safavi SM
J Endocrinol Invest; 2018 Jan; 41(1):33-47. PubMed ID: 28643299
[TBL] [Abstract][Full Text] [Related]
3. Association of fetuin-A with incident type 2 diabetes: results from the MONICA/KORA Augsburg study and a systematic meta-analysis.
Sujana C; Huth C; Zierer A; Meesters S; Sudduth-Klinger J; Koenig W; Herder C; Peters A; Thorand B
Eur J Endocrinol; 2018 Apr; 178(4):389-398. PubMed ID: 29439057
[TBL] [Abstract][Full Text] [Related]
4. Plasma Fetuin-A Levels and Risk of Type 2 Diabetes Mellitus in A Chinese Population: A Nested Case-Control Study.
Wang Y; Koh WP; Jensen MK; Yuan JM; Pan A
Diabetes Metab J; 2019 Aug; 43(4):474-486. PubMed ID: 30968617
[TBL] [Abstract][Full Text] [Related]
5. Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus.
Zhou ZW; Ju HX; Sun MZ; Chen HM; Fu QP; Jiang DM
Clin Chim Acta; 2018 Jan; 476():98-102. PubMed ID: 29174342
[TBL] [Abstract][Full Text] [Related]
6. Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus.
Eleftheriadou I; Grigoropoulou P; Kokkinos A; Mourouzis I; Perrea D; Katsilambros N; Sfikakis PP; Tentolouris N
J Diabetes Complications; 2017 Mar; 31(3):599-604. PubMed ID: 27899247
[TBL] [Abstract][Full Text] [Related]
7. Effects of exercise training on Fetuin-a in obese, type 2 diabetes and cardiovascular disease in adults and elderly: a systematic review and Meta-analysis.
Ramírez-Vélez R; García-Hermoso A; Hackney AC; Izquierdo M
Lipids Health Dis; 2019 Jan; 18(1):23. PubMed ID: 30670052
[TBL] [Abstract][Full Text] [Related]
8. Does fetuin-A mediate the association between pro-inflammatory diet and type-2 diabetes mellitus risk?
Toprak K; Görpelioğlu S; Özsoy A; Özdemir Ş; Ayaz A
Nutr Hosp; 2022 Mar; 39(2):383-392. PubMed ID: 34841880
[TBL] [Abstract][Full Text] [Related]
9. Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis.
Kröger J; Meidtner K; Stefan N; Guevara M; Kerrison ND; Ardanaz E; Aune D; Boeing H; Dorronsoro M; Dow C; Fagherazzi G; Franks PW; Freisling H; Gunter MJ; Huerta JM; Kaaks R; Key TJ; Khaw KT; Krogh V; Kühn T; Mancini FR; Mattiello A; Nilsson PM; Olsen A; Overvad K; Palli D; Quirós JR; Rolandsson O; Sacerdote C; Sala N; Salamanca-Fernández E; Sluijs I; Spijkerman AMW; Tjonneland A; Tsilidis KK; Tumino R; van der Schouw YT; Forouhi NG; Sharp SJ; Langenberg C; Riboli E; Schulze MB; Wareham NJ
Diabetes; 2018 Jun; 67(6):1200-1205. PubMed ID: 29523632
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum fetuin-A levels are associated with grades of retinopathy in type 2 diabetic patients.
Yilmaz A; Yilmaz T; Gunay M
Int Ophthalmol; 2018 Dec; 38(6):2445-2450. PubMed ID: 29071522
[TBL] [Abstract][Full Text] [Related]
11. Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies.
Stefan N; Sun Q; Fritsche A; Machann J; Schick F; Gerst F; Jeppesen C; Joost HG; Hu FB; Boeing H; Ullrich S; Häring HU; Schulze MB
PLoS One; 2014; 9(3):e92238. PubMed ID: 24643166
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
Reinehr T; Karges B; Meissner T; Wiegand S; Fritsch M; Holl RW; Woelfle J
J Clin Endocrinol Metab; 2015 Aug; 100(8):3004-10. PubMed ID: 26052728
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo study.
Laughlin GA; Barrett-Connor E; Cummins KM; Daniels LB; Wassel CL; Ix JH
Diabetes Care; 2013 Jul; 36(7):1994-2000. PubMed ID: 23315604
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate reduces inflammation in obese patients with or without type 2 diabetes mellitus via sirtuin 1/fetuin A axis.
Noureldein MH; Abd El-Razek RS; El-Hefnawy MH; El-Mesallamy HO
Diabetes Res Clin Pract; 2015 Sep; 109(3):513-20. PubMed ID: 26105582
[TBL] [Abstract][Full Text] [Related]
15. Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes.
Zhao ZW; Lin CG; Wu LZ; Luo YK; Fan L; Dong XF; Zheng H
Biomarkers; 2013 Mar; 18(2):160-4. PubMed ID: 23410047
[TBL] [Abstract][Full Text] [Related]
16. Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women.
Ley SH; Sun Q; Jimenez MC; Rexrode KM; Manson JE; Jensen MK; Rimm EB; Hu FB
Diabetologia; 2014 Jan; 57(1):93-101. PubMed ID: 24105100
[TBL] [Abstract][Full Text] [Related]
17. Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
Aroner SA; St-Jules DE; Mukamal KJ; Katz R; Shlipak MG; Criqui MH; Kestenbaum B; Siscovick DS; de Boer IH; Jenny NS; Budoff MJ; Ix JH; Jensen MK
Atherosclerosis; 2016 May; 248():224-9. PubMed ID: 27038419
[TBL] [Abstract][Full Text] [Related]
18. Plasma fetuin-A levels and the risk of type 2 diabetes.
Stefan N; Fritsche A; Weikert C; Boeing H; Joost HG; Häring HU; Schulze MB
Diabetes; 2008 Oct; 57(10):2762-7. PubMed ID: 18633113
[TBL] [Abstract][Full Text] [Related]
19. Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes: A case-control study.
Ali SA; Nassif WM; Abdelaziz DH
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):465-70. PubMed ID: 26823042
[TBL] [Abstract][Full Text] [Related]
20. Fetuin-A and risk of diabetes-related vascular complications: a prospective study.
Birukov A; Polemiti E; Jäger S; Stefan N; Schulze MB
Cardiovasc Diabetol; 2022 Jan; 21(1):6. PubMed ID: 34998417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
